The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application (TM99218423) for the mark ALYPRI. The application, filed on June 4, 2025, specifically covers "Nebulizers for respiration therapy; Nebulizers for medical purposes; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of Asthma, allergy and other respiratory diseases."

This filing indicates a potential new market entrant or product line in the medical device sector, specifically for respiratory treatments. While this is a trademark application and not a regulatory rule, it signals commercial intent and may be relevant for companies operating in the same space, particularly concerning branding and intellectual property. No immediate compliance actions are required for other entities based on this filing.